These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 25735351
1. Matrix metalloproteinase-9 -1562T allele and its combination with MMP-2 -735 C allele are risk factors for breast cancer. Rahimi Z, Yari K, Rahimi Z. Asian Pac J Cancer Prev; 2015; 16(3):1175-9. PubMed ID: 25735351 [Abstract] [Full Text] [Related]
3. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Przybylowska K, Kluczna A, Zadrozny M, Krawczyk T, Kulig A, Rykala J, Kolacinska A, Morawiec Z, Drzewoski J, Blasiak J. Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613 [Abstract] [Full Text] [Related]
4. Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis. Rahimi Z, Abdan Z, Rahimi Z, Razazian N, Shiri H, Vaisi-Raygani A, Shakiba E, Vessal M, Moradi MT. Immunol Invest; 2016 Aug; 45(6):543-52. PubMed ID: 27409770 [Abstract] [Full Text] [Related]
9. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Grieu F, Li WQ, Iacopetta B. Breast Cancer Res Treat; 2004 Dec; 88(3):197-204. PubMed ID: 15609121 [Abstract] [Full Text] [Related]
11. Matrix metalloproteinase-2 C-735T and its interaction with matrix metalloproteinase-7 A-181G polymorphism are associated with the risk of preeclampsia: influence on total antioxidant capacity and blood pressure. Rahimi Z, Lotfi S, Ahmadi A, Jalilian N, Shakiba E, Vaisi-Raygani A, Rahimi Z. J Obstet Gynaecol; 2018 Apr; 38(3):327-332. PubMed ID: 29017408 [Abstract] [Full Text] [Related]
12. Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population. Sugimoto M, Yoshida S, Kennedy S, Deguchi M, Ohara N, Maruo T. J Soc Gynecol Investig; 2006 Oct; 13(7):523-9. PubMed ID: 16990034 [Abstract] [Full Text] [Related]
14. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review. Banday MZ, Sameer AS, Mir AH, Mokhdomi TA, Chowdri NA, Haq E. Gene; 2016 Sep 01; 589(1):81-89. PubMed ID: 27222481 [Abstract] [Full Text] [Related]
15. Association of PON1-L55M Genetic Variation and Breast Cancer Risk: A Case-Control Trial. Farmohammadi A, Momeni A, Bahmani B, Ghorbani H, Ramzanpour R. Asian Pac J Cancer Prev; 2020 Jan 01; 21(1):255-258. PubMed ID: 31983193 [Abstract] [Full Text] [Related]
16. Polymorphisms of matrix metalloproteinases (MMP) gene and breast cancer risk: appraisal of a recent meta-analysis. Wu XY, Chen MB, Wang LQ, Xu Y, Tan Y, Shen WX. Breast Cancer Res Treat; 2011 Nov 01; 130(1):357-8. PubMed ID: 21671019 [No Abstract] [Full Text] [Related]
17. Genetic variations in transcription factor 7-like 2 (TCF7L2) gene: association of TCF7L2 rs12255372(G/T) or rs7903146(C/T) with breast cancer risk and clinico-pathological parameters. Naidu R, Yip CH, Taib NA. Med Oncol; 2012 Jun 01; 29(2):411-7. PubMed ID: 21301999 [Abstract] [Full Text] [Related]